Until recently, a patient could not receive an Alzheimer’s diagnosis without an expensive scan or invasive procedure. Last year, the Food and Drug Administration (FDA) cleared two blood-based biomarker tests—or BBB—that require only a routine blood sample for use in diagnosing Alzheimer’s disease. This is an important step forward in Alzheimer’s care, but it won’t…
Watch live: Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection
Originally reported by The Hill
Related Articles
Far-fetched to think McSweeney faked phone theft, says PM
Far-fetched to think McSweeney faked phone theft, says PM23 minutes agoShareSaveJennifer McKiernanPolitical reporterShar...
Live updates: Trump holds Cabinet meeting as US, Iran dig in and DHS shutdown grinds on
President Trump will hold a Cabinet meeting on Thursday morning amid escalating tensions over the Department of Homeland...
Could Trump’s war in Iran cause another hostage crisis?
Pete Hegseth lacks the foresight, hindsight and wisdom needed to keep Americans safe. Before we get dragged into another...
Trump: Iranian negotiators ‘better get serious soon’
President Trump on Thursday urged Iranian negotiators that they “better get serious soon” as efforts for a c...